FDA Brief

Company record

PAYLESS COMPOUNDERS, LLC

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about PAYLESS COMPOUNDERS, LLC.

Recalls

ReportedClassFirmProduct and reason
Apr 22 Class II PAYLESS COMPOUNDERS, LLC
Drug
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Lack of Assurance of Sterility
FDA notice D-0471-2026